Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1975 • 3,051 citations

BMPD statistical software manual

1988 • 2,605 citations

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1976 • 2,290 citations

Multiple myeloma treated with high dose intravenous melphalan

1987 • 251 citations

Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group Study.

1983 • 156 citations

Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors

1990 • 130 citations

Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients.

1991 • 129 citations

Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors

1990 • 101 citations

Prognostic features in the third MRC myelomatosis trial.

1980 • 97 citations

The survival time of patients with plasmocytic myeloma.

1960 • 91 citations

Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study.

1986 • 88 citations

The prognostic value of serum β 2 microglobulin compared with other presentation features in myelomatosis

1985 • 87 citations

Myelomatosis: Comparison of Melphalan and Cyclophosphamide Therapy

1971 • 57 citations

DOXORUBICIN/B.C.N.U. CHEMOTHERAPY FOR MULTIPLE MYELOMA IN RELAPSE

1976 • 53 citations

Results of the mrc myelomatosis trials for patients entered since 1980

1988 • 53 citations

Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults

1985 • 52 citations

Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan‐prednisone

1990 • 49 citations

Report on the second myelomatosis trial after five years of follow-up.

1980 • 42 citations

Chemotherapy of myeloma: Drug combinations versus single agents, an overview, and comments on acute leukemia in myeloma

1988 • 36 citations

A randomized multicentric study comparing alternating combination chemotherapy (VCMP/VBAP) and melphalan-prednisone in multiple myeloma

1990 • 17 citations

Prognostic factors and staging systems for multiple myeloma: Comparisons between the medical research council studies in the United Kingdom and the Southwest oncology group studies in the United States

1988 • 16 citations

Allogeneic bone marrow transplantation in patients with multiple myeloma

1989 • 13 citations

Treatment of advanced plasma cell myeloma with weekly cyclophosphamide and alternate-day prednisone.

1982 • 13 citations

Cited By (0)

Loading...